{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:09:30Z","timestamp":1790971770712,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,18]],"date-time":"2017-11-18T00:00:00Z","timestamp":1510963200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303514\/2015-9"],"award-info":[{"award-number":["303514\/2015-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00011-017-1094-7","type":"journal-article","created":{"date-parts":[[2017,11,18]],"date-time":"2017-11-18T07:49:44Z","timestamp":1510991384000},"page":"43-55","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Intraurethral injection with LPS: an effective experimental model of prostatic inflammation"],"prefix":"10.1007","volume":"67","author":[{"given":"Fabiana Oliveira","family":"dos Santos Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Costa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edlene Lima","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Santos","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laise Aline Martins","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Tavares","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Karolina Soares e","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyrlene Meiry","family":"da Rocha Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezinha","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Ribeiro","family":"de Melo-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7008-5930","authenticated-orcid":false,"given":"Christina Alves","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,18]]},"reference":[{"key":"1094_CR1","first-page":"59","volume":"43","author":"AR Hamid","year":"2011","unstructured":"Hamid AR, Umbas R, Mochtar CA. Recent role of inflammation in prostate diseases: chemoprevention development opportunity. Acta Med Indones. 2011;43:59\u201365.","journal-title":"Acta Med Indones."},{"key":"1094_CR2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.meegid.2011.03.002","volume":"11","author":"M Omabe","year":"2011","unstructured":"Omabe M, Ezeani M. Infection, inflammation and prostate carcinogenesis. Infect Genet Evol. 2011;11:1195\u20138.","journal-title":"Infect Genet Evol."},{"key":"1094_CR3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/nau.21078","volume":"30","author":"DE Bjorling","year":"2011","unstructured":"Bjorling DE, Wang ZY, Bushman W. Models of inflammation of the lower urinary tract. Neurourol Urodyn. 2011;30:673\u201382.","journal-title":"Neurourol Urodyn"},{"key":"1094_CR4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11255-014-0868-x","volume":"47","author":"X Wang","year":"2015","unstructured":"Wang X, Zhong S, Xu T, Xia L, Zhang X, Zhu Z, Zhang M, Shen Z. Histopathological classification criteria of rat model of chronic prostatitis\/chronic pelvic pain syndrome. Int Urol Nephrol. 2015;47:307\u201316.","journal-title":"Int Urol Nephrol"},{"key":"1094_CR5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.urolonc.2007.05.007","volume":"25","author":"AM Marzo De","year":"2007","unstructured":"De Marzo AM, Nakai Y, Nelson WG. Inflammation, atrophy, and prostate carcinogenesis. Urol Oncol. 2007;25:398\u2013400.","journal-title":"Urol Oncol"},{"key":"1094_CR6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","volume":"60","author":"C Nunzio De","year":"2011","unstructured":"De Nunzio C, Kramer G, Marberger M, Montironi R, Nelson W, Schr\u00f6der F, Sciarra A, Tubaro A. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol. 2011;60:106\u201317.","journal-title":"Eur Urol"},{"key":"1094_CR7","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/pros.21387","volume":"71","author":"G Robert","year":"2011","unstructured":"Robert G, Smit F, Hessels D, Jannink S, Karthaus HF, Aalders T, Jansen K, de la Taille A, Mulders PF, Schalken JA. Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia. Prostate. 2011;71:1701\u20139.","journal-title":"Prostate"},{"key":"1094_CR8","first-page":"1","volume":"31","author":"JE Elkahwaji","year":"2012","unstructured":"Elkahwaji JE. The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer. Res Rep Urol. 2012;31:1\u201310.","journal-title":"Res Rep Urol."},{"key":"1094_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcp.2014.12.023","volume":"94","author":"D Thapa","year":"2015","unstructured":"Thapa D, Ghosh R. Chronic inflammatory mediators enhance prostate cancer development and progression. Biochem Pharmacol. 2015;94:53\u201362.","journal-title":"Biochem Pharmacol"},{"key":"1094_CR10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","volume":"24","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;24:436\u201344.","journal-title":"Nature"},{"key":"1094_CR11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","volume":"7","author":"AM Marzo De","year":"2007","unstructured":"De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gr\u00f6nberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007;7:256\u201369.","journal-title":"Nat Rev Cancer."},{"key":"1094_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.pcan.4500930","volume":"10","author":"EV Vykhovanets","year":"2007","unstructured":"Vykhovanets EV, Resnick MI, MacLennan GT, Gupta S. Experimental rodent models of prostatitis: limitations and potential. Prostate Cancer Prostat Dis. 2007;10:15\u201329.","journal-title":"Prostate Cancer Prostat Dis."},{"key":"1094_CR13","first-page":"1124","volume":"19","author":"TF Li","year":"2013","unstructured":"Li TF, Li WW, Xia XY, Huang YF. Animal models of chronic prostatitis: an update. Zhonghua Nan Ke Xue. 2013;19:1124\u20138.","journal-title":"Zhonghua Nan Ke Xue."},{"key":"1094_CR14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00005392-199907000-00076","volume":"162","author":"BR Fulmer","year":"1999","unstructured":"Fulmer BR, Turner TT. Effect of inflammation on prostatic protein synthesis and luminal secretion in vivo. J Urol. 1999;162:248\u201353.","journal-title":"J Urol"},{"key":"1094_CR15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1464-410X.2011.10796.x","volume":"110","author":"HA Mosli","year":"2012","unstructured":"Mosli HA, Al-Abd AM, El-Shaer MA, Khedr A, Gazzaz FS, Abdel-Naim AB. Local inflammation influences oestrogen metabolism in prostatic tissue. BJU Int. 2012;110:274\u201382.","journal-title":"BJU Int"},{"key":"1094_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pros.20445","volume":"67","author":"JE Elkahwaji","year":"2007","unstructured":"Elkahwaji JE, Zhong W, Hopkins WJ, Bushman W. Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate. 2007;67:14\u201321.","journal-title":"Prostate"},{"key":"1094_CR17","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1038\/sj.bjc.6605370","volume":"101","author":"JE Elkahwaji","year":"2009","unstructured":"Elkahwaji JE, Hauke RJ, Brawner CM. Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. Br J Cancer. 2009;101:1740\u20138.","journal-title":"Br J Cancer"},{"key":"1094_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/pros.21433","volume":"72","author":"BJ Boehm","year":"2012","unstructured":"Boehm BJ, Colopy SA, Jerde TJ, Loftus CJ, Bushman W. Acute bacterial inflammation of the mouse prostate. Prostate. 2012;72:307\u201317.","journal-title":"Prostate"},{"key":"1094_CR19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.urology.2005.04.013","volume":"66","author":"JE Elkahwaji","year":"2005","unstructured":"Elkahwaji JE, Ott CJ, Janda LM, Hopkins WJ. Mouse model for acute bacterial prostatitis in genetically distinct inbred strains. Urology. 2005;66:883\u20137.","journal-title":"Urology."},{"issue":"4","key":"1094_CR20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1464-410X.2006.06110.x","volume":"97","author":"CG Roehrborn","year":"2006","unstructured":"Roehrborn CG. Alfuzosin 10\u00a0mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study. BJU Int. 2006;97(4):734\u201341.","journal-title":"BJU Int."},{"issue":"1","key":"1094_CR21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ucl.2007.09.012","volume":"35","author":"JC Nickel","year":"2008","unstructured":"Nickel JC. Inflammation and benign prostatic hyperplasia. Urol Clin N Am. 2008;35(1):109\u201315.","journal-title":"Urol Clin N Am"},{"issue":"4","key":"1094_CR22","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.eururo.2007.06.038","volume":"52","author":"A Sciarra","year":"2007","unstructured":"Sciarra A, Di Silverio F, Salciccia S, Gomez AM, Gentilucci A, Gentile V. Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol. 2007;52(4):964\u201372.","journal-title":"Eur Urol"},{"issue":"5","key":"1094_CR23","first-page":"312","volume":"13","author":"DM Peehl","year":"1995","unstructured":"Peehl DM, Rubin JS. Keratinocyte growth factor: an androgen-regulated mediator of stromal-epithelial interactions in the prostate. World J Urol. 1995;13(5):312\u20137.","journal-title":"World J Urol"},{"issue":"4","key":"1094_CR24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.juro.2012.06.007","volume":"188","author":"J Ma","year":"2012","unstructured":"Ma J, Gharaee-Kermani M, Kunju L, Hollingsworth JM, Adler J, Arruda EM, Macoska JA. Prostatic fibrosis is associated with lower urinary tract symptoms. J Urol. 2012;188(4):1375\u201381.","journal-title":"J Urol"},{"issue":"5","key":"1094_CR25","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.urology.2013.01.053","volume":"81","author":"F Cantiello","year":"2013","unstructured":"Cantiello F, Cicione A, Salonia A, Autorino R, Tucci L, Madeo I, Damiano R. Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study. Urology. 2013;81(5):1018\u201323.","journal-title":"Urology."},{"key":"1094_CR26","doi-asserted-by":"crossref","first-page":"e100770","DOI":"10.1371\/journal.pone.0100770","volume":"9","author":"L Wong","year":"2014","unstructured":"Wong L, Hutson PR, Bushman W. Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection. PLoS One. 2014;9:e100770.","journal-title":"PLoS One"},{"issue":"1","key":"1094_CR27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/pros.22886","volume":"75","author":"L Wong","year":"2015","unstructured":"Wong L, Hutson PR, Bushman W. Resolution of chronic bacterial-induced prostatic inflammation reverses established fibrosis. Prostate. 2015;75(1):23\u201332.","journal-title":"Prostate"},{"issue":"12","key":"1094_CR28","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1210\/endo.141.12.7811","volume":"141","author":"P Lohrer","year":"2000","unstructured":"Lohrer P, Gloddek J, Nagashima AC, Korali Z, Hopfner U, Pereda MP, Arzt E, Stalla GK, Renner U. Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38 alpha mitogen-activated protein kinase\/nuclear factor-kappaB pathway. Endocrinology. 2000;141(12):4457\u201365.","journal-title":"Endocrinology"},{"issue":"6","key":"1094_CR29","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1124\/mol.64.6.1521","volume":"64","author":"T Ikezoe","year":"2003","unstructured":"Ikezoe T, Yang Y, Heber D, Taguchi H, Koeffler HP. PC-SPES: a potent inhibitor of nuclear factor-kappa B rescues mice from lipopolysaccharide-induced septic shock. Mol Pharmacol. 2003;64(6):1521\u20139.","journal-title":"Mol Pharmacol"},{"issue":"3","key":"1094_CR30","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1124\/jpet.105.092056","volume":"315","author":"HJ Kwak","year":"2005","unstructured":"Kwak HJ, Song JS, Heo JY, Yang SD, Nam JY, Cheon HG. Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation. J Pharmacol Exp Ther. 2005;315(3):1188\u201395.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"1094_CR31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ptr.3537","volume":"26","author":"D Iglesias-Gato","year":"2012","unstructured":"Iglesias-Gato D, Carsten T, Vesterlund M, Pousette A, Schoop R, Norstedt G. Androgen-independent effects of Serenoa repens extract (Prostasan\u00ae) on prostatic epithelial cell proliferation and inflammation. Phytother Res. 2012;26(2):259\u201364.","journal-title":"Phytother Res."},{"key":"1094_CR32","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","volume":"51","author":"G Kramer","year":"2007","unstructured":"Kramer G, Mitteregger D, Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol. 2007;51:1202\u201316.","journal-title":"Eur Urol"},{"key":"1094_CR33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.LAB.0000081388.40145.65","volume":"83","author":"GE Steiner","year":"2003","unstructured":"Steiner GE, Stix U, Handisurya A, Willheim M, Haitel A, Reithmayr F, et al. Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Invest. 2003;83:1131\u201346.","journal-title":"Lab Invest"},{"key":"1094_CR34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1743-6109.2009.01511.x","volume":"7","author":"B Fibbi","year":"2010","unstructured":"Fibbi B, Morelli A, Vignozzi L, Filippi S, Chavalmane A, De Vita G, Marini M, Gacci M, Vannelli GB, Sandner P, Maggi M. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. J Sex Med. 2010;7:59\u201369.","journal-title":"J Sex Med."},{"key":"1094_CR35","first-page":"ra49","volume":"86","author":"TJ Jerde","year":"2009","unstructured":"Jerde TJ, Bushman W. IL-1 induces IGF-dependent epithelial proliferation in prostate development and reactive hyperplasia. Sci Signal. 2009;86:ra49.","journal-title":"Sci Signal"},{"key":"1094_CR36","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/carcin\/bgr206","volume":"32","author":"X Liu","year":"2011","unstructured":"Liu X, Piao YS, Arnold JT. Transforming growth factor \u03b21 increase of hydroxysteroid dehydrogenase proteins is partly suppressed by red clover isoflavones in human primary prostate cancer-derived stromal cells. Carcinogenesis. 2011;32:1648\u201354.","journal-title":"Carcinogenesis"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-017-1094-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-017-1094-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-017-1094-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T04:40:42Z","timestamp":1514954442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-017-1094-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,18]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1007\/s00011-017-1094-7","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,18]]}}}